the partners

news

  • 2018/11/13

    Madrid will play host to the 2nd EPIICAL General Assembly meeting from November 14th to 16th 2018. We look forward […]

    read more
  • 2018/10/05

    September saw the CARMA study complete its enrolment target of 40 patients.

    read more
  • 2018/07/02

    An EPIICAL paper has been accepted for publication in the Journal of Acquired Immune Deficiency Syndromes (JAIDS)

    read more

publications

  • Human Immunodeficiency Virus (HIV) – Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children

    2018/09/04

    Background. Assays to estimate human immunodeficiency virus (HIV) reservoir size require large amounts of blood, which represents a drawback especially […]

    read more

  • Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children

    2018/06/26

    Future strategies aiming to achieve HIV-1 remission are likely to target individuals with small reservoir size. We retrospectively investigated factors associated with HIV-1 DNA levels in European, perinatally HIV-infected children starting ART <6 months of age.

    read more

  • Report from the First EPIICAL General Assembly meeting, 9–11 November 2017, Rome, Italy

    2018/01/22

    The first EPIICAL General Assembly meeting was held in an atmosphere of growing optimism. Many novel and exciting proposals for HIV research studies were […]

    read more

  • The EPIICAL Project: an Emerging Global Collaboration to Investigate Immunotherapeutic Strategies in HIV-Infected Children

    2016/02/16

    The EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies) project arises from the firm belief […]

    read more